KEY
KEYCORPData as of 2026 Q2 (06-30) · 13F snapshot
Summary
KEYCORP (KEY) is held as common stock by 7 tracked hedge-fund managers, with a combined reported value of ~$256.80M; the largest are Steven Cohen, Izzy Englander, Ken Griffin. 3 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 2 new, 4 added, 1 trimmed, 1 closed. 20 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Heating up
Common-stock holders73 also report options
Congress trades20
Price$20.40vs quarter-end-11.50%
Sectors1
This quarter's moves
Top holderNew2
Added4
Trimmed / sold2
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $10.76M— of portfolio467,0002026 Q2
Value $10.02M— of portfolio434,6002026 Q2
Value $9.03M— of portfolio391,6002026 Q2
Value $3.19M— of portfolio138,3002026 Q2
Value $308.9K— of portfolio13,4002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Izzy EnglanderCALL | $10.76M | — | — |
| Ken GriffinCALL | $10.02M | — | — |
| Izzy EnglanderPUT | $9.03M | — | — |
| Ken GriffinPUT | $3.19M | — | — |
| Paul Tudor JonesCALL | $308.9K | — | — |
Insider Trading
Officers · directors · Form 4Open-market purchases and sales (P/S)2
Mohit Ramani
Chief Risk Officer
Sell$568.5K25,000 @ $22.74Traded 2026-07-22Filed 2026-07-24Elizabeth R. Gile
Director
Sell$500.0K23,946 @ $20.88Traded 2026-06-03Filed 2026-06-05
Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.